跳至主要内容
临床试验/NCT00420407
NCT00420407终止早期 1 期

Prospective, Randomized, Double-Blind, Multi-Center Trial of Low Dose Vasopressin Versus Placebo in Traumatic Shock Resuscitation

The University of Texas Health Science Center at San Antonio1 个研究点 分布在 1 个国家目标入组 81 人开始时间: 2007年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
终止
入组人数
81
试验地点
1
主要终点
The Primary Endpoint of This Study Will be Day 30 Mortality.

研究概览

简要总结

Hypothesis: We hypothesize that resuscitation regimens which minimize the total volume of resuscitation fluid, while restoring organ perfusion, will lead to lower morbidity and mortality in critically ill patients following trauma.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • To be eligible for enrollment in the study, a patient must meet all of the follow criteria at assessment:
  • Patient is a male or female patient presumed to be at least 18 years of age;
  • Patient has a systolic blood pressure < 90 mmHg;
  • Patient has clinical evidence of acute traumatic injury;
  • Infusion of study drug must start within one hour following SBP (systolic blood pressure) < 90 mmHg

排除标准

  • A patient meeting any one of the following criteria at hospital assessment is not eligible for enrollment:
  • Patient is admitted to one of the study hospitals' Emergency Department greater than six hours after injury;
  • Patient has received greater than 4 liters fluid since time of injury;
  • Patient is enrolled in another shock trial;
  • Patient is asystolic or requires CPR (cardiopulmonary resucitation) prior to randomization;
  • Female patient is pregnant by report or suspicion;
  • Patient has known "Do Not Resuscitate" orders or visible/identifiable method of objection to participation (e.g., exclusion bracelet);

研究组 & 干预措施

I

Experimental

Vasopressin

干预措施: vasopressin (Drug)

2

Placebo Comparator

bolus of NS (normal saline) followed by continuous infusion of NS, no vasopressin added

干预措施: normal saline control (Drug)

结局指标

主要结局

The Primary Endpoint of This Study Will be Day 30 Mortality.

时间窗: 30 days

Survival of a traumatic injury subject to at least 30 days after admission to the emergency room.

次要结局

  • Level of Vasopressin After Trauma.(12 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验